ATHENS, Ohio--(BUSINESS WIRE)--Diagnostic HYBRIDS announced today that Miguel E. Quinones-Mateu, Ph.D. has joined the company as director of its recently created HIV Program. His principal responsibility will be directing the technical and commercial development activities associated with novel assays for anti-retroviral drug resistance.
